Raymond James initiates Nektar Therapeutics coverage at Market Perform
Raymond James started coverage of Nektar Therapeutics (NKTR) with a Market Perform rating.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results.
Raymond James started coverage of Nektar Therapeutics (NKTR) with a Market Perform rating.